Segment information

9 Months Ended

Apr. 30, 2017

Segment Reporting [Abstract]

Segment information

14. Segment information

Our business is strategically aligned into three segments: Medical Imaging, Ultrasound, and Security and Detection. Our business segments are described as follows:

• Medical Imaging primarily includes systems and subsystems for CT and MRI medical imaging equipment as well as state-of-the-art, selenium-based detectors for screening of breast cancer and other diagnostic applications in mammography.

• Ultrasound includes ultrasound systems and transducers primarily in the urology, surgery, and point-of-care markets.

• Security and Detection includes advanced threat detecting CT systems utilizing our expertise in advanced imaging technology, primarily used in the checked baggage screening at airports worldwide.

The tables below present information about our reportable segments:

	Three Months Ended						Nine Months Ended
	April 30,						April 30,
(in millions)	2017			2016			2017			2016
Product revenue:
Medical Imaging	$	68.2		$	71.9		$	205.9		$	208.7
Ultrasound		34.8			36.8			110.7			115.9
Security and Detection		17.8			17.6			54.8			41.8
Total product revenue	$	120.8		$	126.3		$	371.4		$	366.4
Engineering revenue:
Medical Imaging	$	1.3		$	0.9		$	3.1		$	2.6
Ultrasound		-			0.8			0.2			1.7
Security and Detection		0.1			(0.1	)		0.1			0.1
Total engineering revenue	$	1.4		$	1.6		$	3.4		$	4.4
Net revenue:
Medical Imaging	$	69.5		$	72.9		$	209.0		$	211.3
Ultrasound		34.8			37.6			110.9			117.6
Security and Detection		17.9			17.5			54.9			41.9
Total net revenue	$	122.2		$	128.0		$	374.8		$	370.8
Income (loss) from operations:
Medical Imaging (A)	$	12.2		$	10.2		$	31.3		$	28.2
Ultrasound (B)		(79.3	)		(5.0	)		(89.7	)		(19.5	)
Security and Detection (C )		2.5			2.4			7.2			2.4
Total (loss) income from operations		(64.6	)		7.6			(51.2	)		11.1
Total other income (loss), net		0.10			(0.9	)		(0.4	)		(4.9	)
(Loss) income before income taxes	$	(64.5	)	$	6.7		$	(51.6	)	$	6.2

	As of		As of
	April 30,		July 31,
(in millions)	2017		2016
Identifiable total assets by segment:
Medical Imaging	$	182.8	$	191.1
Ultrasound		146.8		152.5
Security and Detection		42.6		49.8
Total reportable segment assets		372.2		393.4
Corporate assets (D)		193.1		165.6
Total identifiable assets	$	565.3	$	559.0

(A) Includes restructuring charges of $0.2 million and $1.1 million for three months ended April 30, 2017 and April 30, 2016, respectively and $0.4 million and $5.1 million for nine months ended April 30, 2017 and April 30, 2016.  

(B) Includes restructuring charges of $1.8 million and $0.4 million for three months ended April 30, 2017 and April 30, 2016, respectively and $1.9 million and $1.7 million for nine months ended April 30, 2017 and April 30, 2016.

Includes contingent consideration charges of $(2.1) million and $(10.2) million related to Oncura for three and nine months ended April 30, 2017, respectively. Includes asset impairment charges of $3.1 million related to Oncura intangible assets for three and nine months ended April 30, 2017. Includes asset impairment charges of $8.1 million related to PocketSonics intangible assets for three and nine months ended April 30, 2017. Includes goodwill impairment charges of $6.7 million and $16.5 million related to Oncura reporting unit for three and nine months ended April 30, 2017. Includes goodwill impairment charges of $55.1 million related to Ultrasound reporting unit for three and nine months ended April 30, 2017. Includes charges for the BK Medical matter of $0.0 million and $10.1 million for three and nine months ended April 30, 2016 .

(C) Includes restructuring charges of $0.1 million and $0.3 million for three months ended April 30, 2017 and April 30, 2016, respectively and $0.1 million and $1.5 million for nine months ended April 30, 2017 and April 30, 2016.  

Includes asset impairment charges of $0.0 million and $0.6 million related to Pathfinder for three and nine months ended April 30, 2017.

(D) Includes cash and cash equivalents of $144.9 million and $97.3 million as of April 30, 2017 and July 31, 2016, respectively.